Skip to content
Search

Latest Stories

EYE CARE: Seeing solutions for dry eyes

Matthew Olsen says community pharmacists are perfectly placed to help people identify lifestyle factors that might be affecting their eye health…

Dry eye disease, also known as dry eye syndrome, occurs when the eye stops producing enough tears, the tears that are made are of poor quality or the tears evaporate faster than they should. This causes dryness and irritation of the surface of the eye and results in inflammation, discomfort, and damage.[i]


Symptoms include dry, red, itchy or tired eyes, blurred vision and foreign body sensation. From over-the-counter eye drops and heated eye masks, to eyelid-cleansing wipes, there are a multitude of options that can be offered to sufferers to provide relief.

As a result of the pandemic and new living and working patterns, the World Health Organization has indicated dry eye disease is on the rise. This can be attributed to various lifestyle factors including increased screen use and wearing of face masks.

An increase in sufferers seeking advice on the condition in pharmacies has also been reported. It is no surprise that sufferers will turn to their pharmacists for help, support and information on the condition and how it can be managed by treatment options available over-the-counter.

Our recent survey showed that nearly half of Brits would use products recommended by a pharmacist; this is likely due to the compassionate nature of pharmacy teams and more recently, trust gained from keeping their doors open during the pandemic.[ii]

Pharmacists are perfectly placed to help people to identify lifestyle factors that might be affecting their eye health, particularly as public awareness of dry eye disease is still low. The survey also showed that awareness of dry eye disease is currently limited, with over a third (36 per cent) of people not able to recognize the symptoms.2

There is especially little understanding amongst the public around causes and risks, including common lifestyle factors and gender, with women over 40 at a higher risk of developing symptoms. When assessing risk, pharmacists must also consider other health factors when presented with cases of dry eye; for instance, studies show links between dry eye and various conditions such as rheumatoid arthritis and diabetes.[iii][iv]

As pharmacists often see dry eye disease patients at the early stages of their condition, typically their role is screening and directing them to the best place and product to manage their symptoms appropriately. However, they are also in prime position to highlight the benefits of early intervention in preventing eye conditions from worsening and the consequences of leaving these untreated.

If, for example, patients knew that early stages of dry eye disease were reversible, perhaps they would be quicker to seek treatment, and this would result in less patients needing further medical intervention.

Although the majority of dry eye disease cases are simple, patients may well need to be referred to their GP or an optometrist. About 78 per cent of people visiting an ophthalmologist have eye disorders which could have been dealt with in a primary care setting, and pharmacists can play a key role in helping to reduce this number.[v]

It is important that pharmacists work across disciplines to establish and effectively treat dry eye disease, while considering the assessment process involved in diagnoses and tailored management plans for treatment.

Working holistically and taking a multi-disciplinary approach can often be the best way forward, as with dry eye disease, it is not always as simple as treating one single element and expecting success.

Not only this, but as dry eye disease research continues to progress, it is vital that pharmacy teams are comfortable educating people on the benefits of preservative-free options, as often patients prefer cheaper alternatives instead.

The long-term consequences of eye drops containing preservatives can be damaging to the health of the ocular surface, particularly in dry eye disease patients. There seems to be somewhat of a disconnect between evidence supporting the use of preservative-free options and clinical practice.

Indeed, NICE guidance recommends preservative free formulations if a patient with dry eye is intolerant to preservatives, requires drops more than four times per day or uses soft or hybrid contact lens.[vi]

Pharmacists should consider the proven benefits of preservative-free choices when recommending dry eye products. Ultimately, this will improve patient health and wellbeing in the long run.

At Théa, as we build on our commitment to raise awareness of the importance of looking after our eyes, we are placing more emphasis on the ease and importance of eye tests. We hope that pharmacy teams can also help facilitate these conversations within communities as they are frequently people’s first port of call for eye health issues.

Regular eye tests are essential in finding out if someone needs glasses or a new prescription, but even more crucial in picking up general health problems and conditions such dry eye disease.

(Dr Matthew Olsen is head of marketing at Théa Pharmaceuticals.)

References

1 Guy’s & St Thomas’ NHS Foundation Trust. Dry eye syndrome. 2017. Available at: guysandstthomas.nhs.uk/resources/ patientinformation/eye/dry-eyesyndrome. pdf.

2 Thea Pharmaceuticals 2021. NoEyeDea survey [data set]. YouGov. Data on file 

3 Zhang et al. (2016) Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology and clinical characteristics. Journal of Ophthalmology. Article ID 8201053

4 Abd-Allah et al. (2020) Dry eye in rheumatoid arthritis: relation to disease activity. Immunol Med. 43(2): 92-97

5 Doan S et al. Ophthalmol Ther. 2020 Sep;9(3):597-608

6 NICE. Clinical Knowledge Summary ‘Management of dry eye syndrome’. 2017

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less